Crohn’s & Colitis Foundation - Southern Texas Chapter

11/11/2025

This Veterans Day, we honor all who served in the U.S. armed forces. Nearly 70,000 veterans live with Crohn’s disease or ulcerative colitis, some diagnosed while in service and others after being discharged. The Foundation offers a range of resources aimed at supporting veterans living with IBD, including our Facebook support group for veterans with IBD. Learn more: https://bit.ly/49vbT8Z

11/10/2025

Living with ulcerative colitis can mean constant urgency, disrupted plans, and treatments that don’t always work. A new research study is exploring a device designed to help reduce bowel urgency without relying on another medication. Take a quick survey to see if you qualify: https://bit.ly/4eVzm6r

11/08/2025

Collaborating and expanding your professional network are game-changing. Our 2026 Crohn’s & Colitis Congress® program prioritizes meaningful connection with the multidisciplinary leaders who are revolutionizing care.

Plan your itinerary around exciting new receptions like Together We Lead, Innovators in IBD, and more. And don’t miss our main social event, Backstage Pass: A 2000s Throwback! 🎸

Discounted rates are still available — book by December 9 to discover the breakthroughs driving the next generation of Crohn’s & colitis research and treatment.
🔗 https://bit.ly/4mq9FNt

11/05/2025

The Foundation’s Let’s Go There campaign shines a light on real stories of resilience and strength. Meet Sarah, who faced years of fear, denial, and frustration after her ulcerative colitis diagnosis as a young immigrant without access to care. Her perspective changed when her own son was diagnosed with very early onset Crohn’s disease—sparking her determination to fight for both of them and to advocate for others living with IBD. Sarah reminds us that there’s always hope when we speak up, connect, and push for a cure together.

Your journey can inspire others—share your story and help empower our community! https://bit.ly/4i1fv6M

11/04/2025

Dr. Alan Moss, Chief Scientific Officer of the Crohn’s & Colitis Foundation, recently spoke with AARP about common causes of digestive symptoms like bloating, nausea, and diarrhea. He explains how these symptoms can sometimes point to more serious conditions, including Crohn’s disease and ulcerative colitis. Read the full story: https://bit.ly/43Iy4r2

11/03/2025

A new oral treatment improved clinical remission and endoscopic outcomes for patients with moderately to severely active ulcerative colitis who had failed multiple prior therapies, results from two phase III trials showed.

The results, while encouraging, warrant further research, Alan Moss, MD, the Foundation's Chief Scientific Officer, told MedPage Today.

"Obefazimod represents a potential therapy with a new mechanism of action for patients with moderate-severe ulcerative colitis who have failed other treatments," said Moss, who was not involved in the studies. "This short-term study confirms its ability to induce clinical remission and improve colonic inflammation in these patients. However, further studies will be crucial to confirm these benefits over a longer period and in more diverse patient groups." Read more: https://bit.ly/4olysnM

11/03/2025

Upcoming MyIBD Learning Highlighted Patient and Caregiver Education Programs

Your Gut Friendly Fit
Wednesday, November 19 | 8–9 p.m. ET
Join us to explore a hot topic—diet and its role in managing IBD. Experts will review various eating approaches, share nutritional tips, and help you feel confident about making food choices. Register Here: https://www.crohnscolitisfoundation.org/events/your-gut-friendly-fit

11/01/2025

🏅 Early bird catches the savings! Register for our 2025 Turkey Trot by November 7 and save $5 off your registration fee with code “Gobble.” Lace up and trot towards cures for Crohn’s disease and ulcerative colitis this Thanksgiving! https://bit.ly/4nvsXBQ

11/01/2025

Join us for a virtual webinar exploring special diets and their role in managing life with IBD. Hear from IBD experts, including Dr. David Suskind, a pediatric gastroenterologist and professor at Seattle Children’s Hospital and the University of Washington, and David Gardinier, an IBD dietitian at the Cleveland Clinic. They’ll break down different eating approaches, share practical tips, and help you feel more confident in making food choices that support your health and wellbeing. The session will also feature a Q&A with Registered Dietitian Rachel Dyckman, Foundation Professional Member. Sign up today: https://bit.ly/3Wjgw0P

10/31/2025

The CHROMA CD study is currently seeking volunteers in their study being done to test the effectiveness and safety of an investigational medication called SAR442970 compared to placebo in participants with moderate to severe Crohn’s disease (CD).

To be considered for the study, participants must meet these and other criteria:
• 18 to 75 years of age
• Diagnosed with moderate to severe CD at least 3 months ago and is active
• Have taken certain other drug treatments for CD, but either didn’t benefit from those treatments or stopped taking them after having side effects
• Have frequent soft or liquid bowel movements and/or abdominal pain

To learn more about this study click here: https://bit.ly/3WmEGYe

The purpose of the CHROMA-CD study is to find out if SAR442970 is safe and effective in improving the symptoms of CD.

10/30/2025

Come join the virtual Crohn's & Colitis Foundation Veterans Support Group! https://bit.ly/4gI19r8

10/29/2025

Living with ulcerative colitis can mean constant urgency, disrupted plans, and
treatments that don't always work. A new research study is exploring a device designed to help reduce bowel urgency without relying on another medication. Take a quick survey to see if you may qualify. Learn more: https://bit.ly/4eVzm6r